title: Effects of dipeptidyl peptidase-4 inhibitors in a type 2 diabetes patient with failure of glucagon-like peptide-1 receptor agonists.
authors.affiliation: Department of Endocrinology and Metabolism, Shanghai First People's Hospital, Shanghai Jiao Tong University, Shanghai, China.
authors.forename: Yufan
authors.initials: Y
authors.lastname: Wang
authors.forename: Li
authors.initials: L
authors.lastname: Zhao
authors.forename: Qianfang
authors.initials: Q
authors.lastname: Huang
authors.forename: Yongde
authors.initials: Y
authors.lastname: Peng
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D002219:Carbamates / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000188:drug therapy*; D054873:Dipeptidyl-Peptidase IV Inhibitors / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D000077270:Exenatide; D005215:Fasting / Q000097:blood; D005260:Female; D000067757:Glucagon-Like Peptide-1 Receptor; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D000069036:Insulin Glargine; D049528:Insulin, Long-Acting / Q000627:therapeutic use; D008687:Metformin / Q000627:therapeutic use; D008875:Middle Aged; D010455:Peptides / Q000378:metabolism / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use; D011719:Pyrazines / Q000627:therapeutic use*; D018027:Receptors, Glucagon / Q000819:agonists / Q000378:metabolism; D000068900:Sitagliptin Phosphate; D017211:Treatment Failure; D014230:Triazoles / Q000627:therapeutic use*; D014688:Venoms / Q000378:metabolism / Q000627:therapeutic use
chemical_list: D001786:Blood Glucose; D002219:Carbamates; D054873:Dipeptidyl-Peptidase IV Inhibitors; C000593833:GLP1R protein, human; D000067757:Glucagon-Like Peptide-1 Receptor; D007004:Hypoglycemic Agents; D049528:Insulin, Long-Acting; D010455:Peptides; D010880:Piperidines; D011719:Pyrazines; D018027:Receptors, Glucagon; D014230:Triazoles; D014688:Venoms; D000069036:Insulin Glargine; C072379:repaglinide; D008687:Metformin; D000077270:Exenatide; D000068900:Sitagliptin Phosphate
keywords: dipeptidyl peptidase-4 inhibitors; glucagon-like peptide-1 receptor agonists; tailored therapy